Table 4.
PCS |
MCS |
|||
---|---|---|---|---|
Characteristic | β value | 95% CI | β value | 95% CI |
|
|
|||
Histologic response | −1.7 | −6.2-2.7 | 3.3 | −2.3-9.0 |
Exudates | 0.2 | −3.9-4.3 | −1.6 | −6.7-3.6 |
Rings | 3.8 | 0.3-7.2 | −0.2 | −5.6-4.2 |
Edema | 2.5 | −1.7-6.7 | 4.4 | −1.0-9.7 |
Furrows | −1.4 | −5.9-3.2 | 1.0 | −4.8-6.8 |
Stricture | 2.8 | −1.5-7.2 | −1.2 | −6.7-4.3 |
Dilation performed | −2.5 | −6.7-1.7 | 1.2 | −4.1-6.5 |
Budesonide therapy | 3.4 | −0.5-7.3 | 0.1 | −4.8-5.1 |
Fluticasone therapy | 4.4 | −1.1-9.8 | −5.5 | −12.5-1.5 |
Targeted diet | −0.1 | −4.1-3.9 | −0.9 | −6.0-4.2 |
Empiric diet | −0.2 | −4.4-3.9 | −7.2 | −12.5- −1.9 |
PPI therapy | 0.1 | −3.2-3.5 | 1.4 | −2.9-5.6 |
Dysphagia Likert | −0.3 | −0.9-0.4 | −0.4 | −1.2-0.4 |
Pain with swallowing | 4.5 | 1.6-7.4 | 3.4 | −0.2-7.0 |